Analyst Richard Law initiated coverage of the health-care stock with an outperform rating.
You are here: Home / Credit Suisse says this biotech stock can surge 100%, citing an opportunity in obesity-related hypertension
Market News and Views
Analyst Richard Law initiated coverage of the health-care stock with an outperform rating.